Status:
COMPLETED
The Effect of Surfactant Dose on Outcomes in Preterm Infants With RDS
Lead Sponsor:
Chiesi UK
Collaborating Sponsors:
The Leeds Teaching Hospitals NHS Trust
Imperial College London
Conditions:
Respiratory Distress Syndrome
Bronchopulmonary Dysplasia
Eligibility:
All Genders
Brief Summary
A prospective observational study using de-identified data from the Neonatal Network Research Database (NNRD) supplemented by additional information on dose, method of surfactant administration and do...
Detailed Description
The rationale for this study is the clinical relevance of understanding whether surfactant dose affects neonatal outcomes in infants with RDS who are treated in the immediate postnatal period. In a r...
Eligibility Criteria
Inclusion
- \<37 weeks gestational age Requiring surfactant for Respiratory Distress Syndrome Record of birth weight available Born after study initiation
Exclusion
- 37 weeks gestation age or above Parental opt-out
Key Trial Info
Start Date :
October 26 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 30 2024
Estimated Enrollment :
2973 Patients enrolled
Trial Details
Trial ID
NCT03808402
Start Date
October 26 2018
End Date
March 30 2024
Last Update
May 31 2025
Active Locations (29)
Enter a location and click search to find clinical trials sorted by distance.
1
William Harvey Hospital
Ashford, Kent, United Kingdom, TN24 0LZ
2
Birmingham Women's Hospital
Birmingham, United Kingdom, B15 2TG
3
Birmigham Heartlands Hospital
Birmingham, United Kingdom, B9 5SS
4
Royal Bolton Hospital
Bolton, United Kingdom, BL4 0JR